On SSRIs: Why Is One of the Most Widely Prescribed Medications So Controversial?

In this episode of On the Mind, host Dr. Daniel Knoepflmacher speaks with Dr. Richard Friedman and Dr. James Kocsis, two senior professors of psychiatry at Weill Cornell Medicine, about the growing controversy surrounding SSRIs and related antidepressants. Prompted by recent statements from federal health officials and the ensuing media coverage, they examine claims that these medications are over-prescribed, addictive, linked to youth violence, and ineffective, weighing each against the available evidence. Drawing on decades of clinical and research experience, Drs. Friedman and Kocsis distinguish discontinuation symptoms from addiction, discuss approaches to tapering, and explain how the serotonin hypothesis has evolved and why placebo response complicates antidepressant trials. The conversation also addresses why SSRIs draw more scrutiny than other commonly prescribed medications, the very real problem of untreated depression, and why psychiatrists need to communicate more clearly with the public. This is a candid, engaging discussion that grounds a heated public debate in data, distinguishing solid evidence from misleading anecdotes and viral misinformation.